We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.4B
AUM Growth
+$1.5B
Cap. Flow
+$1.66B
Cap. Flow %
7.75%
Top 10 Hldgs %
50.4%
Holding
201
New
31
Increased
27
Reduced
32
Closed
37

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.41B
2
CHTR icon
Charter Communications
CHTR
+$462M
3
CBRE icon
CBRE Group
CBRE
+$375M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$314M
5
VMW
VMware, Inc
VMW
+$285M

Top Sells

Rank Stock Value
1
EFX icon
Equifax
EFX
+$249M
2
IQV icon
IQVIA
IQV
+$239M
3
BIIB icon
Biogen
BIIB
+$172M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$130M
5
TMO icon
Thermo Fisher Scientific
TMO
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 31.13%
2 Technology 23.99%
3 Financials 9.09%
4 Communication Services 6.05%
5 Industrials 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAL icon
76
TAL Education Group
TAL
$6.87B
$12.4M 0.06%
+1,365,000
New +$9.57M
SLNO
77
DELISTED
Soleno Therapeutics
SLNO
$11.4M 0.05%
+388,000
New +$2.35M
CD
78
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$10.8M 0.05%
+1,300,000
New +$10.6M
CRNX icon
79
Crinetics Pharmaceuticals
CRNX
$8.92B
$10.8M 0.05%
+361,904
New +$7.46M
SCRM
80
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$10.5M 0.05%
1,000,000
– –
VYGR icon
81
Voyager Therapeutics
VYGR
$201M
$10M 0.05%
1,292,000
– –
AXSM icon
82
Axsome Therapeutics
AXSM
$10.9B
$8.78M 0.04%
125,653
-147,147
-54% -$11M
RIO icon
83
Rio Tinto
RIO
$164B
$8.75M 0.04%
137,500
– –
LBPH
84
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$8.68M 0.04%
1,560,500
+560,500
+56% +$3.61M
APLS
85
DELISTED
Apellis Pharmaceuticals
APLS
$7.38M 0.03%
194,053
+154,000
+384% +$6.76M
SLAM
86
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$6.15M 0.03%
570,396
– –
VNET
87
VNET Group
VNET
$2.09B
$5.56M 0.03%
1,775,000
– –
GHIX
88
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$5.2M 0.02%
500,000
– –
GOSS icon
89
Gossamer Bio
GOSS
$87M
$5.11M 0.02%
+6,130,272
New +$7.06M
NDAQ icon
90
Nasdaq
NDAQ
$52.9B
$4.98M 0.02%
+102,500
New +$5.19M
FRXB
91
DELISTED
Forest Road Acquisition Corp. II
FRXB
$4.15M 0.02%
400,000
– –
IVCP
92
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.19M 0.01%
300,000
– –
BACA
93
DELISTED
Berenson Acquisition Corp. I
BACA
$2.96M 0.01%
285,715
– –
VERV
94
DELISTED
Verve Therapeutics
VERV
$2.8M 0.01%
+211,293
New +$3.4M
TVRD
95
Tvardi Therapeutics
TVRD
$23.4M
$2.8M 0.01%
46,294
– –
TVTX icon
96
Travere Therapeutics
TVTX
$5.78B
$2.43M 0.01%
+271,517
New +$3.83M
ARYD
97
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.17M 0.01%
200,000
– –
MTAL
98
DELISTED
Metals Acquisition
MTAL
$1.89M 0.01%
+157,500
New +$1.76M
MTAL.WS
99
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$1.66M 0.01%
825,000
– –
GATE
100
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.57M 0.01%
150,000
– –
2 3
4
5 6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Farallon Capital Management held 201 positions worth $21.4B, up 7.5% from $19.9B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Farallon Capital Management deployed $1.66B of net new capital in Q3 2023, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Charter Communications: 1,111,341 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was IQVIA, an estimated $239M trimmed.

  • Farallon Capital Management's largest Q3 2023 buy was Charter Communications: 1,111,341 shares worth $489M.
  • Farallon Capital Management added most to Activision Blizzard in Q3 2023, an estimated $1.41B increase.
  • Farallon Capital Management's biggest Q3 2023 reduction was IQVIA, cutting an estimated $239M.
  • Farallon Capital Management fully exited Equifax in Q3 2023, selling an estimated $249M.
  • Farallon Capital Management's ten largest holdings make up 50% of its $21.4B portfolio in Q3 2023.
  • Farallon Capital Management opened 31 new positions and closed 37 in Q3 2023.
  • Farallon Capital Management's portfolio value rose 7.5% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.